Cormorant Asset Management, LP has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $943 Million distributed in 44 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Moon Lake Immunotherapeutics with a value of $332M, Edgewise Therapeutics, Inc. with a value of $90.2M, Bridge Bio Pharma, Inc. with a value of $69.1M, Arcellx, Inc. with a value of $68.9M, and Janux Therapeutics, Inc. with a value of $54M.
Examining the 13F form we can see an decrease of $324M in the current position value, from $1.27B to 943M.
Cormorant Asset Management, LP is based out at Boston, MA
Below you can find more details about Cormorant Asset Management, LP portfolio as well as his latest detailed transactions.
